Pharma, Congress, and Kids
Costs of pediatric clinical trials are on the rise -- but companies forge ahead.
The State of Pharma--By the Stats
No surprises here: Medicare, emerging markets boost drug sales--but mostly generics.
Schering-Plough Gets Hitched! Who Knew?
Merger with Organon strengthens late-stage pipeline.
